A new platform for detecting small molecules quickly and easily
Official title: Diagnostics on demand: a biosensor platform for multiplexed small molecule detection
Funded at University of California Riverside · NIH-10909333 · Data updated 2026-11-12
This study is working on a new type of sensor that uses plant receptors to quickly and cheaply detect small molecules, like drugs, which could help make medical tests easier and more accessible for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $412,036 |
| NIH project number | 5R01GM151616-02 |
| Project ID | NIH-10909333 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals requiring rapid diagnostic testing for small molecule detection, such as those undergoing drug testing or needing specific medical evaluations.
✕Less likely to help
Patients who do not require small molecule detection or those with conditions unrelated to the substances being tested may not benefit from this research.
What this research studies
This research focuses on developing a biosensor platform that simplifies the detection of small molecules, which are important in various fields such as medicine and environmental monitoring. By utilizing a plant receptor, the researchers aim to create a faster and more cost-effective method for developing diagnostic tests compared to traditional antibody-based approaches. The technology will allow for the routine creation of sensors that can detect a wide range of substances, including drugs and natural products, making it accessible for point-of-care diagnostics and other applications.
Why it matters
Potential benefit: If successful, this research could lead to quicker and cheaper diagnostic tests for patients, improving access to essential health information.
How similar studies have gone: Other research has shown promise in developing biosensors for small molecules, indicating that this approach has potential for success.
Where this research is happening
-
University of California Riverside
Riverside, United States Active
Researchers
- Principal investigator: Cutler, Sean — University of California Riverside
- Study coordinator: Cutler, Sean
Related research
Other NIH-funded projects on the same topics.
-
Cellular programming by plant signaling in cancer and other diseases
Scientists are studying how plant cell signals control gene activity in the nucleus and mitochondria to understand faulty regulation that can occur in cancers and other disorders.
-
Caveolin-1 helps brain vessels stay healthy after juvenile concussion
A study in kids and young adults looks at how a protein called Caveolin-1 affects brain blood vessels after a mild concussion and whether targeting it could protect long-term brain health.
-
How tiny cell antennae control signals linked to birth defects and cancer
Researchers are looking for new proteins in cells' tiny antennae that control signals involved in certain birth defects and cancers to point toward future treatments.
-
New ways to make natural compounds that could fight cancer, Alzheimer's, and inflammation
A scientist team will make and test natural-looking molecules to see if they can block proteins linked to cancer, Alzheimer's disease, and inflammatory conditions.
-
Promoting Coping Skills to Reduce Health Gaps in Teens and Young Adults
A study tests a shift-and-persist coping approach to help racial/ethnic minority teens and young adults handle stress and reduce risks for chronic disease.
-
Laser particle barcoding to track live cells and their omics in breast cancer
A new technique uses special laser-coded particles to follow individual breast cancer cells in real time while linking their live behavior to multi-omics data.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.